Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1974 2
1976 2
1979 2
1981 1
1983 1
1984 2
1985 1
1986 4
1987 1
1988 2
1990 6
1991 1
1992 2
1993 2
1995 1
1998 1
2000 1
2001 1
2002 2
2003 2
2005 3
2006 7
2007 10
2008 14
2009 9
2010 6
2011 8
2012 12
2013 15
2014 9
2015 17
2016 17
2017 19
2018 14
2019 10
2020 16
2021 30
2022 23
2023 21
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

287 results

Results by year

Filters applied: . Clear all
Page 1
[Sex-specific differences in surgical confidence: results of the Endo Workshop of the German Society of Residents in Urology 2022].
Siech C, Kluth LA, Konopka M, Reimann M, Plage H, Lichy I, Gerdes B, Kasperek J, Humke C, Marks P, Fisch M, Karakiewicz PI, Chun FKH, Schäfer T, Meyer CP, Kaulfuss JC. Siech C, et al. Among authors: reimann m. Urologie. 2024 Aug 27. doi: 10.1007/s00120-024-02429-w. Online ahead of print. Urologie. 2024. PMID: 39190147 German.
A Transcriptomic Biomarker Predicting Linezolid-Associated Neuropathy During Treatment of Drug-Resistant Tuberculosis.
Zielinski N, Baiceanu D, Dragomir A, Heyckendorf J, Ibraim E, Köhler N, Leschczyk C, Popa C, Rachow A, Sachsenweger J, Sanchez Carballo P, Schaub D, Zeeb H, Tulu B, DiNardo AR, Lange C, Reimann M. Zielinski N, et al. Among authors: reimann m. Pathog Immun. 2024 Jun 25;9(2):25-42. doi: 10.20411/pai.v9i2.705. eCollection 2024. Pathog Immun. 2024. PMID: 38939039 Free PMC article.
Gemtuzumab ozogamicin plus midostaurin in combination with standard '7 + 3' induction therapy in newly diagnosed AML: Results from the SAL-MODULE phase I study.
Röllig C, Schliemann C, Ruhnke L, Fransecky L, Heydrich BN, Hanoun M, Noppeney R, Schäfer-Eckart K, Wendelin K, Mikesch JH, Middeke JM, Reimann M, Fiebig F, Zukunft S, Wermke M, Serve H, Platzbecker U, Müller-Tidow C, Baldus CD, Bornhäuser M. Röllig C, et al. Among authors: reimann m. Br J Haematol. 2024 Jun;204(6):2254-2258. doi: 10.1111/bjh.19436. Epub 2024 Apr 9. Br J Haematol. 2024. PMID: 38593353 Clinical Trial.
287 results